📌At a Glance: GHK-Cu Reconstitution Arithmetic
- High-Mass Research Vials: GHK-Cu is distributed in the largest vial masses on the site (50 mg and 100 mg), yielding high-concentration solutions where a single syringe unit contains 100 mcg to 500 mcg.
- Copper Complex vs. Net Peptide: The molecule is a copper(II) chelate complex (Gly-His-Lys:Cu2+). Label milligrams may reflect the total complex salt mass or net tripeptide; check your analytical Certificate of Analysis.
- Vial Liquid Capacity Check: Adding 3.0 mL to 5.0 mL of bacteriostatic water requires verifying that the physical glass vial container (e.g. 5 mL or 10 mL serum vial) has sufficient liquid capacity.
- Syringe Calibration: All volumetric conversions assume a standard U-100 insulin syringe (100 units = 1.0 mL, or 0.01 mL per unit graduation mark).
GHK-Cu (copper tripeptide-1) is widely utilized as an active cosmetic and dermatological topical ingredient. However, injectable GHK-Cu is not an FDA-approved drug, has no approved systemic pharmaceutical indications, and has not been cleared for human injection therapy. Compounding of injectable copper peptides is restricted under FDA bulk drug substance safety guidance (Category 2). Lyophilized solid-cake vials sold online are unapproved research chemicals without federal good manufacturing practice (cGMP) inspection.
- This calculator cannot provide medical advice, diagnosis, or clinical administration schedules.
- It cannot determine whether a vendor's labeled mass denotes gross copper complex salt or net unchelated peptide base.
- It cannot verify the chemical purity, sterility, or peptide content of unapproved research vials.
- It cannot guarantee solution stability beyond documented USP <797> multi-dose preservative limits.
This tool converts volumetric liquid measurements and syringe tick marks only. It does not provide medical guidance, dosing schedules, or clinical administration protocols. Review our Medical & Research Disclaimer.
What Is GHK-Cu and Why Does It Require Specialized Math?
In laboratory evaluations, GHK-Cu is delivered as an intensely blue, freeze-dried lyophilized powder cake in glass serum vials. Reconstitution is the laboratory addition of a sterile diluent, primarily bacteriostatic water (sterile water preserved with 0.9% benzyl alcohol). Because GHK-Cu vials contain massive quantities of active compound compared to other research peptides (typically 50 mg to 100 mg per vial), our ghk-cu dosage calculator provides exact dilution arithmetic to ensure manageable draw graduations and prevent mathematical oversights.
GHK-Cu Dosage Chart
This reference chart translates intended milligram test masses into volumetric draw units on a standard U-100 syringe across 50 mg and 100 mg research vials with 2 mL, 3 mL, and 5 mL of diluent. These numbers represent illustrative mathematical conversions across standardized benchmark test amounts (1.0 mg, 1.5 mg, 2.0 mg, 3.0 mg) and do not represent clinical advice, therapeutic recommendations, or administration protocols.
| Vial Size | Bac Water Added | Concentration | Example Amount | Draw Units (U-100) |
|---|---|---|---|---|
| 50 mg | 2.0 mL | 25.0 mg/mL | 1.0 mg | 4.0 Units |
| 50 mg | 2.0 mL | 25.0 mg/mL | 2.0 mg | 8.0 Units |
| 50 mg | 3.0 mL | 16.67 mg/mL | 1.0 mg | 6.0 Units |
| 50 mg | 3.0 mL | 16.67 mg/mL | 2.0 mg | 12.0 Units |
| 50 mg | 5.0 mL | 10.0 mg/mL | 1.0 mg | 10.0 Units |
| 50 mg | 5.0 mL | 10.0 mg/mL | 2.0 mg | 20.0 Units |
| 100 mg | 3.0 mL | 33.33 mg/mL | 2.0 mg | 6.0 Units |
| 100 mg | 5.0 mL | 20.0 mg/mL | 2.0 mg | 10.0 Units |
GHK-Cu 50 mg and 100 mg Vial Conversion Matrix (with 5 mL Option)
The table below outlines resulting solution concentrations, unit potencies, and draw units required per 1.0 mg across standard 50 mg and high-potency GHK-Cu 100mg vials reconstituted with 2 mL, 3 mL, and 5 mL of diluent. For comprehensive diluent selection details, read our dedicated reference on how much bacteriostatic water for GHK-Cu.
| Vial Mass (mg) | Diluent Added (mL) | Concentration (mg/mL) | Potency per Unit (mcg/U) | Units per 1.0 mg Draw |
|---|---|---|---|---|
| 50 mg | 2.0 mL | 25.0 mg/mL | 250.0 mcg/U | 4.0 Units |
| 50 mg | 3.0 mL | 16.67 mg/mL | 166.7 mcg/U | 6.0 Units |
| 50 mg | 5.0 mL | 10.0 mg/mL | 100.0 mcg/U | 10.0 Units |
| 100 mg | 2.0 mL | 50.0 mg/mL | 500.0 mcg/U | 2.0 Units |
| 100 mg | 3.0 mL | 33.33 mg/mL | 333.3 mcg/U | 3.0 Units |
| 100 mg | 5.0 mL | 20.0 mg/mL | 200.0 mcg/U | 5.0 Units |
Worked Calculation Example: 50 mg Vial with 5.0 mL Diluent
- Vial Mass: 50.0 mg solid lyophilized cake
- Diluent Added: 5.0 mL sterile Bacteriostatic Water
- Target Test Amount: 1.0 mg (1,000 mcg) illustrative calculation
- Syringe Standard: U-100 insulin syringe (100 units = 1.0 mL, or 0.01 mL per unit)
- Step 1: Calculate concentration: 50.0 mg ÷ 5.0 mL = 10.0 mg/mL (10,000 mcg/mL).
- Step 2: Determine volumetric draw: 1.0 mg ÷ 10.0 mg/mL = 0.10 mL.
- Step 3: Convert volume to U-100 syringe units: 0.10 mL × 100 units/mL = 10.0 Units.
- Step 4: Mathematical Back-Check: 10.0 units × 0.01 mL/unit = 0.10 mL. 0.10 mL × 10.0 mg/mL = 1.0 mg of GHK-Cu. Result matches target exactly.
Drawing 10.0 units on a U-100 syringe delivers exactly 1.0 mg of GHK-Cu.
Note: If this same 50 mg vial were reconstituted with only 2.0 mL of water (25 mg/mL), a 1.0 mg draw would equal just 4.0 units (0.04 mL), which is significantly harder to measure accurately on a 1.0 mL syringe barrel.
What Does the Label's Milligram Mass Include? Copper Complex vs. Net Peptide
1. Copper Chelate Stoichiometry: In pure chemical terms, GHK is a tripeptide (molecular formula C14H24N6O4, MW ~340.38 g/mol). When chelated with copper(II), it forms GHK-Cu (molecular formula C14H22CuN6O4, MW ~401.91 g/mol), frequently supplied as an acetate or chloride salt. On commercial research vials, the stated milligram mass (e.g., '50 mg') typically denotes the total mass of the copper-tripeptide complex salt rather than unchelated peptide base. The reconstitution math on this page calculates concentration based on the mass entered on the vial label; researchers conducting stoichiometric research should review their analytical Certificate of Analysis (COA) to confirm whether mass values specify gross complex salt or net peptide.
2. Physical Vial Container Capacity: Standard peptide serum vials hold either 2 mL, 3 mL, 5 mL, or 10 mL of liquid. Because GHK-Cu vials contain up to 100 mg of powder, researchers often choose 3 mL to 5 mL of diluent to moderate concentration. Before adding 5.0 mL of diluent, confirm that your glass vial has a 5 mL or 10 mL capacity. Injecting 5 mL of water into a standard 3 mL vial will overfill the container, displace the rubber stopper, and compromise sterility.
For universal principles on managing liquid volume conversions, consult our tutorial on how to calculate peptide dosage.
Syringe Unit Resolution and Measurement Precision (per 1.0 mg Target Draw)
Because GHK-Cu vials contain high total masses, each individual graduation mark on a U-100 syringe contains a substantial quantity of active peptide. This table illustrates what percentage of an illustrative 1.0 mg target draw is contained in a single syringe unit mark.
| Vial Setup | Concentration | Peptide Mass per Unit | One Unit as % of 1.0 mg Target | Practical Measurement Note |
|---|---|---|---|---|
| 50 mg in 2.0 mL | 25.0 mg/mL | 250 mcg (0.25 mg) | 25.0% | High density: 1 unit error = 25% deviation |
| 50 mg in 5.0 mL | 10.0 mg/mL | 100 mcg (0.10 mg) | 10.0% | Moderate: 10 units = 1.0 mg, clear visual marks |
| 100 mg in 2.0 mL | 50.0 mg/mL | 500 mcg (0.50 mg) | 50.0% | Critical: 1 unit contains half of the 1.0 mg draw |
| 100 mg in 5.0 mL | 20.0 mg/mL | 200 mcg (0.20 mg) | 20.0% | Elevated: Requires 0.3 mL or 0.5 mL fine graduation syringe |
GHK-Cu Physical Characteristics & Laboratory Handling
GHK-Cu exhibits an unmistakable deep royal blue coloration in both dry lyophilized form and aqueous solution due to d-d electronic transitions of the coordinated copper(II) center. This blue tint is an intrinsic chemical property of the copper complex, not a sign of chemical contamination or oxidation.
When reconstituting, inject bacteriostatic water slowly down the interior glass wall. Allow the cake to hydrate passively, then swirl gently in circular motions until fully dissolved into a crystal-clear, deep blue solution. Avoid vigorous shaking. Store reconstituted vials upright under continuous refrigeration at 2°C–8°C (USP <659>). Under FDA multi-dose sterile vial guidance and USP <797> standards, multi-dose vials preserved with 0.9% benzyl alcohol should be discarded within 28 days of first puncture unless product labeling specifies a shorter limit. For the complete universal standard operating procedure, consult our guide on how to reconstitute peptides safely.
Common Calculation & Measurement Mistakes
GHK-Cu is a copper-tripeptide chelate complex salt. The mass printed on the vial (e.g., 50 mg) represents the total complex salt. Laboratory protocols requiring molar quantification must consult an analytical COA to verify net peptide content.
Attempting to add 5.0 mL of bacteriostatic water to a 50 mg or 100 mg cake supplied in a standard 3 mL glass serum vial will cause liquid overflow, stopper displacement, and complete loss of sterility. Always check vial container volume before adding diluent.
Adding only 1.0 mL or 2.0 mL of water to a 100 mg vial creates a dense 50 mg/mL solution where a 1.0 mg draw is only 2 units (0.02 mL). Measuring 2 units on a standard syringe introduces severe visual alignment errors. Adding 3.0 mL to 5.0 mL creates a more manageable draw volume.
U-100 syringes contain 100 units per mL (0.01 mL/unit). U-40 syringes contain 40 units per mL (0.025 mL/unit). Drawing 10 units on a U-40 syringe delivers 0.25 mL instead of 0.10 mL—causing an unintentional 2.5× volumetric error.
Comparing GHK-Cu Arithmetic with Tissue Repair Peptides
Understanding how GHK-Cu arithmetic compares to neighboring research peptides clarifies volumetric dynamics:
• Compared to BPC-157: BPC-157 is calculated in microgram increments (250 mcg to 500 mcg) using 5 mg or 10 mg vials. In stark contrast, GHK-Cu vials contain 50 mg to 100 mg, operating on a 10× to 20× higher total mass scale and requiring larger diluent volumes.
• Compared to TB-500: TB-500 is typically packaged in 2 mg, 5 mg, or 10 mg vials and calculated in milligram quantities. While both compounds utilize milligram scales, GHK-Cu's higher vial masses require greater diluent volumes to avoid micro-unit graduation errors.
• Compared to KPV Peptide: KPV is an anti-inflammatory tripeptide evaluated in cellular models. Both GHK-Cu and KPV are tripeptides, but GHK-Cu contains a chelated copper cofactor that accounts for a portion of its molecular mass.
• Compared to Klow Blend Calculator: Multi-peptide blends frequently incorporate GHK-Cu alongside BPC-157 and KPV. In blend vials, GHK-Cu's concentration must be evaluated independently from the other constituent peptides.
Reconstitution Protocol Summary
Lyophilized GHK-Cu dissolves readily in sterile bacteriostatic water when slow-injection techniques are observed.
U-100 Syringe Graduation & Measurement Line (GHK-Cu)
Standard Reconstitution Protocol
Review our standardized 5-step sterile reconstitution guide for full vial preparation, alcohol disinfection, and needle safety protocols.
Universal Step-by-Step Reconstitution Guide→❄️ Storage & Shelf-Life Notice (GHK-Cu)
Store reconstituted GHK-Cu solutions refrigerated at 2°C–8°C (36°F–46°F). Never freeze reconstituted liquid solutions.
⚠️ Common Preparation Mistakes to Avoid
Common errors include assuming complex mass equals free peptide, overfilling small glass vials beyond their liquid capacity, and confusing U-40 with U-100 syringes.
GHK-Cu Dosing FAQ
Why are GHK-Cu vials so large compared with other research peptides?↓
Does the label's milligram mass include the chelated copper?↓
How large is one syringe unit when reconstituting a 100 mg vial with 2 mL of water?↓
What glass vial capacity is required to add 5 mL of bacteriostatic water?↓
Why does reconstituted GHK-Cu have an intense deep blue color?↓
Related Peptide Calculators & Stacks
Related Reconstitution & Dosing Guides
View All FAQs→Scientific & Regulatory References
View Full Sources Registry→The mathematical formulas on this page are deterministic volumetric conversions. Non-mathematical parameters, regulatory status notes, and chemical safety guidelines are referenced directly to the primary sources cataloged below:
- [1]Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene DataInternational Journal of Molecular Sciences (PubMed PMID: 30044426)•Type: peer reviewed•Verified: 2026-10-20
Overview of copper-tripeptide (Gly-His-Lys) biochemistry, chelation thermodynamics, and tissue remodeling.
- [2]Safety Risks Associated with Certain Bulk Drug Substances Nominated for 503A/503B CompoundingU.S. Food and Drug Administration•Type: fda communication•Verified: 2026-10-20
FDA Category 2 classification covering safety considerations for BPC-157, AOD-9604, and CJC-1295.
- [3]Analytical Procedures and Acceptance Criteria for Synthetic Peptide Drug SubstancesFDA CDER / USP General Chapter <1503> Quality Attributes of Synthetic Peptides•Type: standard•Verified: 2026-10-20
Technical specifications for RP-HPLC purity, mass spectrometry sequence confirmation, counter-ions, and endotoxin testing.
- [4]Embecta Ultra-Fine™ U-100 Insulin Syringe Product Specificationsembecta (formerly BD Diabetes Care)•Type: manufacturer spec•Verified: 2026-11-08
Manufacturer specifications for sterile single-use U-100 insulin syringes (0.3 mL, 0.5 mL, and 1.0 mL capacities with 1-unit and 1/2-unit scales).
- [5]Bacteriostatic Water for Injection, USP Multi-Dose Prescribing DetailsU.S. National Library of Medicine (DailyMed / Hospira / Pfizer)•Type: fda label•Verified: 2026-10-20
Sterile multi-dose diluent specification containing 0.9% (9 mg/mL) benzyl alcohol preservative.
- [6]USP General Chapter <797>: Pharmaceutical Compounding — Sterile PreparationsUnited States Pharmacopeial Convention (USP)•Type: standard•Verified: 2026-10-20
Standards for beyond-use dates (BUD), refrigeration controls (2°C–8°C), and multi-dose sterility.
- [7]USP General Chapter <659>: Packaging and Storage RequirementsUnited States Pharmacopeial Convention (USP)•Type: standard•DOI: 10.31003/USPNF_M2773_06_01•Verified: 2026-11-08
Official compendial definitions for cold storage (2°C to 8°C), freezer conditions, and protection from light and freezing.
- [8]FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight LossU.S. Food and Drug Administration (FDA CDER)•Type: fda communication•Verified: 2026-11-08
FDA safety alert detailing risks of unapproved compounded GLP-1 drugs, dosing errors, lack of pre-market review, improper cold-chain shipping temperatures, and recommendation to discard multi-dose sterile vials 28 days after first puncture.